These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 6716577)

  • 1. Marketing status of Fluosol.
    DasGupta AK
    JAMA; 1984 May; 251(19):2515. PubMed ID: 6716577
    [No Abstract]   [Full Text] [Related]  

  • 2. Status of Fluosol-DA 20%.
    Carr M
    JAMA; 1984 Jun; 251(22):2928. PubMed ID: 6716618
    [No Abstract]   [Full Text] [Related]  

  • 3. FDA committee questions Fluosol efficacy; US approval not imminent.
    Marwick C
    JAMA; 1983 Nov; 250(19):2585-6. PubMed ID: 6632147
    [No Abstract]   [Full Text] [Related]  

  • 4. O2 and CO2 solubility of the fluorocarbon emulsion fluosol-DA 20% and O2 and CO2 dissociation curves of blood-fluosol-DA 20% mixtures.
    Grote J; Steuer K; Müller R; Söntgerath C; Zimmer K
    Adv Exp Med Biol; 1985; 191():453-61. PubMed ID: 3938602
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of moderate hemodilution with fluosol-DA or normal saline on acetaminophen disposition in the rat.
    Shrewsbury RP; White LG
    Experientia; 1990 Feb; 46(2):213-7. PubMed ID: 2303130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cold protected hearts extract oxygen from Fluosol-DA during cardiopulmonary bypass.
    Gartman DM; McDonagh PF; Geha AS
    Adv Exp Med Biol; 1984; 180():443-50. PubMed ID: 6534118
    [No Abstract]   [Full Text] [Related]  

  • 7. Fluosol-DA in radiation therapy.
    Lustig RA; McIntosh NL
    Prog Clin Biol Res; 1986; 211():29-38. PubMed ID: 3960931
    [No Abstract]   [Full Text] [Related]  

  • 8. [Studies on the effect of Fluosol DA (FC) against acute cerebral ischemia (author's transl)].
    Fujita K; Kusunoki T; Tamaki N; Matsumoto S
    Neurol Med Chir (Tokyo); 1981 Dec; 21(12):1209-13. PubMed ID: 6173782
    [No Abstract]   [Full Text] [Related]  

  • 9. Extracorporeal circulation with perfluorochemicals (Fluosol-DA).
    Hoshino S; Iwaya F; Igari T; Kanno M; Honda K
    J Cardiovasc Surg (Torino); 1982; 23(6):463-9. PubMed ID: 7153234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxygen supply and microcirculation of the beating dog heart after haemodilution with fluosol DA 20%.
    Harrison DK; Günther H; Vogel H; Ellermann R; Brunner M; Höper J; Kessler M
    Adv Exp Med Biol; 1985; 191():445-52. PubMed ID: 3832859
    [No Abstract]   [Full Text] [Related]  

  • 11. Whole body oxygenation using intraperitoneal perfusion of fluorocarbons.
    Faithfull NS; Klein J; van der Zee HT; Salt PJ
    Br J Anaesth; 1984 Aug; 56(8):867-72. PubMed ID: 6430312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [New treatment for cerebral vasospasm: fluosol-DA, 20% and improvement of cerebral ischemia].
    Nagasawa S; Naruo Y; Yonekawa Y; Hoshimaru M; Oda Y; Handa H
    Neurol Med Chir (Tokyo); 1982 Aug; 22(8):626-32. PubMed ID: 6183603
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of different oxygen concentrations during hemodilution with Fluosol or LMW-Dextran in rabbits.
    Beisbarth H; Madjidi A; Frey R
    Prog Clin Biol Res; 1983; 122():373-80. PubMed ID: 6192450
    [No Abstract]   [Full Text] [Related]  

  • 14. Fluosol-DA: an artificial blood for total cardiopulmonary bypass.
    Engelman RM; Rousou JH; Dobbs WA
    Ann Thorac Surg; 1981 Dec; 32(6):528-35. PubMed ID: 7316587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebral cortical oxygenation and perfusion during progressive normovolaemic haemodilution with hetastarch (volex) and fluosol-DA.
    Shinozuka T; Nemoto EM; Winter PM
    Adv Exp Med Biol; 1987; 215():109-15. PubMed ID: 2445178
    [No Abstract]   [Full Text] [Related]  

  • 16. Hemodilution and myocardial oxygen supply. The influence of fluosol-DA.
    Vogel H; Günther H; Harrison DK; Anderer W; Kessler M; Peter K
    Adv Exp Med Biol; 1989; 248():653-61. PubMed ID: 2782181
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparative studies with Fluosol, Dextran, their mixture, or autologous blood in experimental hypovolemic shock.
    Madjidi A; Beisbarth H; Frey R
    Prog Clin Biol Res; 1983; 122():391-7. PubMed ID: 6192451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stability of perfluorocarbon blood substitutes determined by sedimentation field-flow fractionation.
    Yang FS; Caldwell KD; Giddings JC; Astle L
    Anal Biochem; 1984 May; 138(2):488-94. PubMed ID: 6742424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Fluosol-DA and oxygen breathing on adriamycin antitumor activity and cardiac toxicity in mice.
    Teicher BA; Holden SA; Crawford JM
    Cancer; 1988 Jun; 61(11):2196-201. PubMed ID: 3365649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An experimental study on fluorocarbons as blood substitutes.
    Motta G; Ratto GB; De Barbieri A; Tomellini M; Rovatti M; Sacco A; Castagnola M
    Ital J Surg Sci; 1983; 13(2):89-93. PubMed ID: 6629736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.